Dasatinib (Dyronib) 50 mg x 60 tabs for senolytic research generic sprycel

Description

Dyronib branded 50 mg dasatinib tabs, as used in multiple senolytic trials and research, alongside with quercetin

Dasatinib (generic Sprycel) is originally a targeted therapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) but it got in the focus due to its use in multiple senolytic trials and research, used alongside with quercetin (commonly referred to as D+Q)

https://www.alzforum.org/therapeutics/dasatinib-quercetin

Senolytic Treatment with Dasatinib and Quercetin Confirmed to Reduce the Burden of Senescent Cells in Human Patients